Fairmount Funds Management LLC Diversified Active

CIK: 0001802528 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 14, 2025

Total Value ($000): $1,111,423 (100.0% shares, 0.0% debt)

Holdings (17)

DNTH DIANTHUS THERAPEUTICS INC 11.7%

Value ($000) $130,138 Shares 3,307,191 Est. Cost $17.22 Unrealized +48.4%

COGT COGENT BIOSCIENCES INC 11.6%

Value ($000) $129,289 Shares 9,003,418 Est. Cost $9.55 Unrealized +24.0%

AXSM AXSOME THERAPEUTICS INC 8.9%

Value ($000) $99,003 Shares 815,176 Est. Cost $49.79 Unrealized +126.3%

APGE APOGEE THERAPEUTICS INC 7.3%

Value ($000) $81,393 Shares 2,048,647 Est. Cost $22.03 Unrealized +73.3%

ELVN ENLIVEN THERAPEUTICS INC 6.8%

Value ($000) $75,973 Shares 3,711,444 Est. Cost $18.70 Unrealized +7.8%

VRDN VIRIDIAN THERAPEUTICS INC 6.7%

Value ($000) $74,665 Shares 3,459,913 Est. Cost $16.55 Unrealized +9.0%

ORKA ORUKA THERAPEUTICS INC 6.4%

Value ($000) $71,252 Shares 3,705,262 Est. Cost $32.55 Unrealized -54.5%

KNSA KINIKSA PHARMACEUTICALS INTL 6.2%

Value ($000) $68,839 Shares 1,772,839 Est. Cost $21.28 Unrealized +52.7%

SRRK SCHOLAR ROCK HLDG CORP 6.1%

Value ($000) $67,927 Shares 1,824,031 Est. Cost $32.27 Unrealized +8.4%

SYRE SPYRE THERAPEUTICS INC 6.1%

Value ($000) $67,343 Shares 4,018,101 Est. Cost $31.80 Unrealized -48.7%

NUVL NUVALENT INC 5.7%

Value ($000) $62,920 Shares 727,563 Est. Cost $22.67 Unrealized +248.8%

ABVX ABIVAX SA 5.4%

Value ($000) $60,571 Shares 713,434 Est. Cost $84.90 Unrealized —

ZBIO ZENAS BIOPHARMA INC 3.8%

Value ($000) $42,020 Shares 1,892,806 Est. Cost $17.98 Unrealized -9.5%

JBIO JADE BIOSCIENCES INC 2.5%

Value ($000) $27,792 Shares 3,220,368 Est. Cost $33.31 Unrealized -75.5%

— ASTRIA THERAPEUTICS INC 2.3%

Value ($000) $25,874 Shares 3,554,129 Est. Cost $9.99 Unrealized —

CBIO CRESCENT BIOPHARMA INC. 1.5%

Value ($000) $16,502 Shares 1,387,866 Est. Cost $21.15 Unrealized -37.3%

IKT INHIBIKASE THERAPEUTICS INC 0.9%

Value ($000) $9,923 Shares 6,125,000 Est. Cost $2.49 Unrealized -30.6%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
DNTH	DIANTHUS THERAPEUTICS INC	3,307,191	$130,138	11.7%	$17.22	+48.4%	COM	252828108
COGT	COGENT BIOSCIENCES INC	9,003,418	$129,289	11.6%	$9.55	+24.0%	COM	19240Q201
AXSM	AXSOME THERAPEUTICS INC	815,176	$99,003	8.9%	$49.79	+126.3%	COM	05464T104
APGE	APOGEE THERAPEUTICS INC	2,048,647	$81,393	7.3%	$22.03	+73.3%	COM	03770N101
ELVN	ENLIVEN THERAPEUTICS INC	3,711,444	$75,973	6.8%	$18.70	+7.8%	COM	29337E102
VRDN	VIRIDIAN THERAPEUTICS INC	3,459,913	$74,665	6.7%	$16.55	+9.0%	COM	92790C104
ORKA	ORUKA THERAPEUTICS INC	3,705,262	$71,252	6.4%	$32.55	-54.5%	COM	687604108
KNSA	KINIKSA PHARMACEUTICALS INTL	1,772,839	$68,839	6.2%	$21.28	+52.7%	ORD SHS CL A	G52694109
SRRK	SCHOLAR ROCK HLDG CORP	1,824,031	$67,927	6.1%	$32.27	+8.4%	COM	80706P103
SYRE	SPYRE THERAPEUTICS INC	4,018,101	$67,343	6.1%	$31.80	-48.7%	COM NEW	00773J202
NUVL	NUVALENT INC	727,563	$62,920	5.7%	$22.67	+248.8%	COM	670703107
ABVX	ABIVAX SA	713,434	$60,571	5.4%	$84.90	—	SPONSORED ADS	00370M103
ZBIO	ZENAS BIOPHARMA INC	1,892,806	$42,020	3.8%	$17.98	-9.5%	COM	98937L105
JBIO	JADE BIOSCIENCES INC	3,220,368	$27,792	2.5%	$33.31	-75.5%	COM NEW	008064206
—	ASTRIA THERAPEUTICS INC	3,554,129	$25,874	2.3%	$9.99	—	COM	04635X102
CBIO	CRESCENT BIOPHARMA INC.	1,387,866	$16,502	1.5%	$21.15	-37.3%	COM	G2545C104
IKT	INHIBIKASE THERAPEUTICS INC	6,125,000	$9,923	0.9%	$2.49	-30.6%	COM NEW	45719W205